← Open Payments lookup

RACHEL RAGER: Open Payments

NPI 1841505377 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,694 in 92 payments from 18 companies in 2025. Trend: 2023 $1,196 · 2024 $1,239 · 2025 $1,694

Food & beverage: $1,694
CompanyPaymentsAmount
Madrigal Pharmaceuticals18$290
GENZYME CORPORATION12$275
Janssen Biotech, Inc.11$189
Gilead Sciences, Inc.8$153
Takeda Pharmaceuticals U.S.A., Inc.9$145
Regeneron Healthcare Solutions, Inc.4$94
Lilly USA, LLC4$80
ABBVIE INC.4$77
Ardelyx, Inc.4$76
Ipsen Biopharmaceuticals, Inc3$66

Products named: DUPIXENT, REZDIFFRA, TREMFYA, ENTYVIO, OMVOH, IBSRELA, IQIRVO, RINVOQ.

Industry payments across NE — which companies pay providers there.